SOR I Regional Reports

OMNI is pleased to share Regional SOR I GPRA Reports! Similar to the state report, these reports contain aggregated intake GPRA data specific to the CSBs in each of the five regions from the entirety of the SOR I grant (June 2019 - September 30th, 2020).

These reports are identical to the CSB-level SOR I GPRA reports that were created earlier this year (CSB-level reports are located in CSB's individual Dropbox folders). We recommend using the Regional SOR I GPRA reports to better understand your CSB's individual SOR I GPRA report. Please note that only CSBs with at least 15 intake GPRAs in SOR I received a report.

Please review the five Regional SOR I GPRA reports on our Reports page!

If you have any questions or feedback regarding the report, please don't hesitate to reach out to us at SORSupport@omni.org.

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.